Quest Laboratories (NSE:QUESTLAB) Free Cash Flow per Share: ₹-9.73 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
46 GF Score
Price ₹89.70
! 5 Warning Signs
View Full Analysis

What is Quest Laboratories Free Cash Flow per Share?

Quest Laboratories NSE:QUESTLAB 46 Free Cash Flow per Share is ₹-9.73 as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 46/100. The stock has 5 warning signs investors should review. Among 660 Drug Manufacturers companies, Quest Laboratories ranks worse than 151515% on this metric.

Quest Laboratories's Free Cash Flow per Share for the six months ended in Mar. 2026 was ₹-7.82. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-9.73.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the FCF Growth Rate using Free Cash Flow per Share data.

The historical rank and industry rank for Quest Laboratories's Free Cash Flow per Share or its related term are showing as below:

NSE:QUESTLAB's 3-Year FCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.75
* Ranked among companies with meaningful 3-Year FCF Growth Rate only.

Quest Laboratories  (NSE:QUESTLAB) Free Cash Flow per Share Explanation

Free Cash Flow is very close to Warren Buffett's definition of Owner's Earnings, except that in Warren Buffett's Owner's Earnings, the spending for Property, Plant, and Equipment is only for maintenance (replacement), while in the Free Cash Flow calculation, the cost of new Property, Plant, and Equipment due to business expansion is also deducted. There, Free Cash Flow is more conservative than Owner's Earnings.

In Don Yacktman's calculation of forward rate of return, he uses Free Cash Flow for the calculation. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation.

This is what Yacktman said in his March 2012 interview - when the S&P 500 was at 1400:

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is because research shows that five years is the length of the typical business cycle.

Therefore, as of Mar26, Quest Laboratories's Forward Rate of Return (Yacktman) % is

Forward Rate of Return (Yacktman) % (Mar26)=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=-2.66183333/104.4+0.2
=17.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Free Cash Flow within a report period can be affected by management's decisions of capital spending. Therefore, it is important to look at long term when it comes to Free Cash Flow.


Quest Laboratories Free Cash Flow per Share Related Terms


Quest Laboratories Free Cash Flow per Share Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Free Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Free Cash Flow per Share Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Free Cash Flow per Share
Get a 7-Day Free Trial 0.93 8.02 1.27 -16.35 -9.74

Quest Laboratories Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Free Cash Flow per Share Get a 7-Day Free Trial Premium Member Only 2.99 0.00 0.00 -1.90 -7.82

NSE:QUESTLAB vs LLY, JNJ, ABBV: Free Cash Flow per Share Comparison

For the Drug Manufacturers - General subindustry, Quest Laboratories's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Laboratories Price-to-Free-Cash-Flow vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Quest Laboratories's Price-to-Free-Cash-Flow falls into.


NSE:QUESTLAB
46GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Free Cash Flow per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Free Cash Flow per Share Calculation

Free Cashflow per Share is the amount of Free Cashflow per outstanding share of the company's stock.

Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company.

Note: GuruFocus does not calculate Free Cash Flow Per Share when Capital Expenditure is 0.

Quest Laboratories's Free Cash Flow Per Share for the fiscal year that ended in Mar. 2026 is calculated as

Free Cash Flow Per Share(A: Mar. 2026 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(-107.161+-52.5)/16.395
=-159.661/16.395
=-9.74

Quest Laboratories's Free Cash Flow Per Share for the quarter that ended in Mar. 2026 is calculated as

Free Cash Flow Per Share(Q: Mar. 2026 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(-120.121+-8.364)/16.421
=-128.485/16.421
=-7.82

Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-9.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Free Cash Flow per Share of ₹-9.73 mean?
Quest Laboratories (NSE:QUESTLAB) has a Free Cash Flow per Share of ₹-9.73 as of Mar. 2026. Free cash flow per share represents the pre-share value of cash following operating and capital expenditures. View historical data on Quest Laboratories and its competitors. According to the industry distribution chart, Quest Laboratories ranks #999999 out of 660 companies in the Drug Manufacturers industry.
Is Quest Laboratories' Free Cash Flow per Share too high?
Quest Laboratories' current Free Cash Flow per Share is ₹-9.73. Based on the distribution chart, Quest Laboratories ranks #999999 out of 660 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Quest Laboratories has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Free Cash Flow per Share compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #999999 out of 660 companies for Free Cash Flow per Share. This places Quest Laboratories in the lower half of its industry. The industry median Free Cash Flow per Share is 8.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Free Cash Flow per Share for a Drug Manufacturers company?
The median Free Cash Flow per Share among Drug Manufacturers companies is 8.75, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Free Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Free Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Free Cash Flow per Share mean?
A high Free Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Free cash flow per share represents the pre-share value of cash following operating and capital expenditures. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median Free Cash Flow per Share is 8.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current Free Cash Flow per Share is ₹-9.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Free Cash Flow per Share of ₹-9.73. The current Free Cash Flow per Share is ₹-9.73. Quest Laboratories' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Free Cash Flow per Share calculated?
Free Cash Flow per Share is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Free Cash Flow per Share is ₹-9.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
46GF Score

Get the complete analysis for NSE:QUESTLAB

Free Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹89.70
Price